Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:e32-e37

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calaghan, S. C.
Right arrow Articles by White, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calaghan, S. C.
Right arrow Articles by White, E.
Related Collections
Right arrow Contractile function
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Ion channels/membrane transport
(Circulation Research. 2001;88:e32.)
© 2001 American Heart Association, Inc.


Research Commentary

Modulation of Ca2+ Signaling by Microtubule Disruption in Rat Ventricular Myocytes and Its Dependence on the Ruptured Patch-Clamp Configuration

S. C. Calaghan, J.-Y. Le Guennec, E. White

From the School of Biomedical Sciences (S.C.C., E.W.), University of Leeds, Leeds, UK; Nutrition, Croissance, Cancer EA2103 (J.-Y.G.), University of Tours, Tours, France.

Correspondence to Dr S. Calaghan, School of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UK. E-mail s.c.calaghan{at}leeds.ac.uk


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—In the absence of hypertrophic proliferation of microtubules, microtubule disruption by colchicine does not modulate contraction of adult cardiac myocytes. However, Gomez et al (Circ Res. 2000;86:30–36) recently reported that disruption of microtubules by colchicine in ruptured patch-clamped myocytes increased ICa,L density and [Ca2+]i transient amplitude and depressed the response of these parameters to the ß-adrenoceptor agonist isoproterenol. These effects were ascribed to stimulation of adenylyl cyclase by increased intracellular free tubulin. In the present study, we show that in intact rat ventricular myocytes, 2 to 4 hours of exposure to 10 µmol/L colchicine had no effect on shortening or [Ca2+]i transient amplitude or on the amplitude of ICa,L in perforated patch-clamped cells, under basal conditions and after stimulation with 1 µmol/L isoproterenol. However, in ruptured patch-clamped myocytes, basal ICa,L was 2-fold higher after treatment with colchicine compared with vehicle and, in contrast to vehicle-treated cells, ICa,L did not increase in response to isoproterenol. Cell width decreased during ruptured patch-clamp experiments in colchicine-treated but not vehicle-treated myocytes. We conclude that in cells with intact sarcolemma, colchicine does not modulate Ca2+ signaling or the response to ß stimulation. However, the combination of microtubule disruption by colchicine and the ruptured patch configuration activates ICa,L and attenuates the response to ß stimulation. We propose that these effects may be due to loss of free tubulin by intracellular dialysis or to increased sensitivity to mechanical stimulation as a result of microtubule disruption. These findings have important implications for cardiomyopathies associated with decreased free tubulin or a diminished microtubular network. The full text of this article is available at http://www.circresaha.org.


Key Words: cardiac myocyte • contraction • calcium signaling • microtubules • colchicine


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Microtubules are hollow protein cylinders of {alpha}- and ß-tubulin heterodimers. Although they form a major component of the cardiac cell cytoskeleton, their functional role within the myocyte remains unclear. Microtubules have been implicated in pathological conditions including ischemia,1 cardiac hypertrophy, and failure.2 In some (but not all) cardiac hypertrophies, microtubules have been shown to be proliferated.3 4 5 6 Such microtubule proliferation is associated with a depression of cardiac contractile function,3 4 5 6 7 which has been shown to be normalized by the microtubule-disrupter colchicine,3 4 5 6 thereby directly implicating microtubules in the modulation of contraction. It has been suggested that microtubule proliferation may modify contraction by increasing sarcomeric load,3 although contractile depression associated with chemical proliferation of the microtubules by taxol is accompanied by a decrease in the amplitude of the intracellular [Ca2+]i transient.7

In the absence of prior hypertrophic proliferation, a number of studies have shown that microtubule disruption by colchicine does not increase contractility in either multicellular preparations or single myocytes in the rat,5 8 9 10 cat,3 4 6 11 12 guinea pig,13 and dog.14 However, the recent study by Gomez et al15 published in Circulation Research showed that in ruptured patch-clamped rat ventricular myocytes, disruption of microtubules by colchicine increased ICa,L density and the amplitude of the [Ca2+]i transient and depressed the response of these parameters to the ß-adrenoceptor agonist isoproterenol. These effects were ascribed to stimulation of adenylyl cyclase by free tubulin within the cell. Given the involvement of microtubules in some models of hypertrophic contractile dysfunction and the central role of ß-adrenergic stimulation in cardiac function, the work by Gomez et al15 raises interesting questions about the possible role of microtubules in the heart. However, the increase in [Ca2+]i and ICa,L seen by Gomez et al15 appears inconsistent with the lack of contractile effect of colchicine reported by others.

To date, no single study has measured the response of contraction, [Ca2+]i, and ICa,L to colchicine or the effect of colchicine on the response of these parameters to ß-adrenergic stimulation. We have undertaken such an investigation, and our data allow us to reconcile the apparent inconsistencies between Gomez et al15 and previous contractile studies. Disruption of microtubules by colchicine had no effect on Ca2+ signaling in intact cells or under perforated patch-clamp conditions but appeared to make cells more sensitive to some aspect of the ruptured patch-clamp configuration, resulting in activation of ICa,L and attenuation of the response to ß-adrenergic stimulation. Our observations suggest that this effect on Ca2+ signaling is unlikely to be associated with an increase in free tubulin, and alternative interpretations are discussed.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Single ventricular myocytes were isolated enzymatically from hearts of male Wistar rats (200 to 250 g) as described previously.16 Rats supplied by Central Biomedical Services at the University of Leeds were used in accordance with the Home Office Guidance on the Operation of the Animals (Scientific Procedures) Act of 1986.

Immunofluorescence Confocal Microscopy
The microtubules were labeled with monoclonal antibody to ß-tubulin (1:200; Sigma Chemical Co) and FITC-conjugated donkey anti-mouse IgG (1:50; Jackson), as described by Howarth et al.7 Sections of {approx}2 µm thickness taken longitudinally through the cell at the level of the nucleus were imaged using confocal laser microscopy (Leica True Confocal Scanner SP). Settings were identical for imaging of vehicle- and colchicine-treated cells.

Measurement of Contraction and [Ca2+]i
Contraction and [Ca2+]i were measured in cells loaded with fura-2-AM (Molecular Probes).17 Cells were electrically stimulated at 0.5 Hz, and cell shortening was monitored using a video edge-detection system (Crescent Electronics). Myocytes were alternately illuminated by 340 and 380 nm light, and the fluorescent emission at 510 nm was recorded. The ratio of the emitted fluorescence at the two excitation wavelengths (340/380 ratio) was calculated to provide an index of [Ca2+]i. Experiments were performed at 22°C to 25°C.

Perforated and Ruptured Patch-Clamp Studies
For perforated patch-clamp studies, pipettes were filled with PP solution (see Solutions) containing 400 µg/mL amphotericin B. Access resistance using this configuration was 13.8±0.7 M{Omega}, and time to peak of ICa,L, an indicator of good access, was 7.5±0.5 ms. For ruptured patch experiments, pipettes were filled with RP solution (see Solutions). Cell capacitance and series resistance were electronically compensated by {approx}60%. Pipette tip resistance was 2 to 3 M{Omega}. ICa,L was elicited from a holding potential of -80 mV by a 300-ms step depolarization to -40 mV (to inactivate INa), followed by a 300-ms depolarization to 0 mV (at a stimulation frequency of 0.5 Hz). Current-voltage relationships for ICa,L were measured using a conventional protocol that was preceded at each potential by 4 priming depolarizations to 0 mV. In ruptured patch experiments, cell size was also recorded from a video image of the cell at selected time points after establishment of the whole-cell configuration.

Solutions
HEPES-based bathing solution contained (mmol/L) NaCl 113, HEPES 5, Na2HPO4 1, MgSO4 · 7H2O 1, KCl 5, CaCl2 1, glucose 10, sodium acetate 20, insulin 5 U/L; pH 7.4. PP pipette solution contained (mmol/L) KCl 10, NaCl 10, MgCl2 · 6H2O 1, CaCl2 1, potassium glutamate 110, HEPES 5; pH 7.2 with KOH. RP pipette solution contained (mmol/L) KCl 130, MgCl2 · 6H2O 1, NaH2PO4 1, Na2 phosphocreatine 3.6, MgATP 5, HEPES 10, EGTA 0.1; pH 7.2 with KOH. Stock solutions of colchicine were dissolved in methanol. The final concentration of methanol in colchicine-containing solutions was 0.01% or 0.1%. Cells were exposed to colchicine (1 or 10 µmol/L) or vehicle (0.01% or 0.1% vol/vol) for 2 hours and then studied within a further 2-hour period. All experiments were conducted in the presence of colchicine or vehicle as appropriate. Myocytes from each heart were always used to study the effects of both vehicle and colchicine in parallel. Contraction, [Ca2+]i, and ICa,L were measured under basal conditions and at steady state after perfusion with 1 µmol/L isoproterenol.

Statistics
Results are expressed as mean±SEM of n observations. Statistical analysis was performed using the Student’s t test (paired and unpaired) or 2-way repeated-measures ANOVA followed by Bonferroni t test for multiple comparisons.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Effect of Colchicine on Microtubules
Immunofluorescence techniques were used to establish the effect of colchicine on the microtubules in rat ventricular myocytes. Figure 1Down shows the effect of 2-hour exposure of myocytes to 10 µmol/L colchicine. Fluorescence intensity in sections taken at the level of the nucleus in colchicine-treated cells was reduced to 57% of that recorded in vehicle-treated cells (P<0.01) confirming that, in our study, colchicine caused disruption of the microtubules.



View larger version (49K):
[in this window]
[in a new window]
 
Figure 1. Immunofluorescence labeling of ß-tubulin in rat ventricular myocytes exposed to colchicine. Immunofluorescence confocal micrographs showing the organization and distribution of microtubules at the level of the nucleus in myocytes exposed to vehicle (A) or 10 µmol/L colchicine (B) for 2 hours. See Materials and Methods for details of immunolabeling protocol. Bars=15 µm. Mean fluorescence intensity normalized to section area is summarized in panel C. Open bar indicates vehicle-treated cells (Veh); hatched bars are colchicine-treated cells (Col). Values are mean+SEM of 31 cells. **P<0.01 vs vehicle-treated cells (Student’s t test).

Effect of Colchicine on Contraction and [Ca2+]i
Initially, a study of the effect of colchicine (at the two concentrations used most widely in the literature) on contraction and [Ca2+]i in myocytes with intact sarcolemma was carried out. Exposure of rat ventricular myocytes to 1 and 10 µmol/L colchicine for 2 hours had no effect on either the magnitude or kinetics of cell shortening (TableDown, top). Diastolic [Ca2+]i was significantly higher (P<0.01) in cells exposed to 10 µmol/L colchicine; however, at neither concentration of colchicine did we observe any significant effect on [Ca2+]i transient amplitude (TableDown, bottom). The only effect of colchicine on transient kinetics was a reduction (P<0.01) in the t1/2 of the transient at 10 µmol/L colchicine (TableDown, bottom).


View this table:
[in this window]
[in a new window]
 
Table 1. Effect of Colchicine (1 and 10 µmol/L) on Contraction and [Ca2+]i Transient in Rat Ventricular Myocytes

Additional studies examining the effect of colchicine on the response to ß-adrenergic stimulation were then performed. Figure 2Down shows the effect of 10 µmol/L colchicine on the contractile response to the ß-adrenergic agonist isoproterenol. Colchicine did not modify the effect of isoproterenol on either the magnitude or kinetics of contraction. Neither did colchicine affect the increase in [Ca2+]i transient amplitude with isoproterenol (Figure 3Down). In this series of experiments, the only effect of colchicine on the [Ca2+]i transient was an attenuation of the increase in time to peak of the transient observed in the presence of isoproterenol (Figure 3Down).



View larger version (44K):
[in this window]
[in a new window]
 
Figure 2. Effect of colchicine on contraction of rat ventricular myocytes. Myocytes were exposed to either vehicle (Veh) or 10 µmol/L colchicine (Col) for 2 hours and contraction was studied at room temperature under basal conditions or at steady state after perfusion with 1 µmol/L isoproterenol. A, Representative records of shortening in cells exposed to either vehicle or colchicine under basal conditions ({circ}) and in the presence of isoproterenol (•). Shortening under basal conditions with colchicine is normalized to that under basal conditions in the vehicle-treated cell for ease of comparison. B, Shortening expressed as a percentage of resting cell length. C, Time to peak of the contraction. D, Time to half-relaxation. Open bars are under basal conditions, and hatched bars are in the presence of isoproterenol. All bars are mean+SEM of 11 to 12 observations. *P<0.05, **P<0.01, ***P<0.001 compared with respective group under basal conditions (paired Student’s t test). There were no significant differences between colchicine- and vehicle-treated cells.



View larger version (42K):
[in this window]
[in a new window]
 
Figure 3. Effect of colchicine on [Ca2+]i transient in rat ventricular myocytes. Fura-2–loaded myocytes were exposed to either vehicle (Veh) or 10 µmol/L colchicine (Col) for 2 hours, and [Ca2+]i transients were recorded at room temperature under basal conditions or at steady state after perfusion with 1 µmol/L isoproterenol. A, Representative records of [Ca2+]i transients in cells exposed to either vehicle or colchicine under basal conditions ({circ}) and in the presence of isoproterenol (•). [Ca2+]i transient under basal conditions with colchicine is normalized to that under basal conditions in the vehicle-treated cell for ease of comparison. B, [Ca2+]i transient amplitude. C, Time to peak of the [Ca2+]i transient. D, Time to half-decay of the transient. Open bars are under basal conditions, and hatched bars are in the presence of isoproterenol. All bars are mean+SEM of 9 to 11 observations. *P<0.05, ***P<0.001 compared with respective group under basal conditions (Student’s t test). The only significant effect of colchicine was a reduction in the time to peak of the transient in the presence of isoproterenol (+P<0.05 compared with respective vehicle-treated group).

Effect of Colchicine on ICa,L
The effect of colchicine on ICa,L was measured using both amphotericin perforated patch-clamp and ruptured patch-clamp techniques. Basal ICa,L was similar in perforated patch-clamped cells in the presence of vehicle and colchicine (8.7±1.5 versus 10.0±1.9 pA/pF; n=8), and, in both groups of cells, ICa,L increased {approx}2-fold (P<0.05) in response to isoproterenol (Figure 4CDown). However, in ruptured patch-clamped myocytes, basal ICa,L was significantly higher (P<0.05) in colchicine-treated cells (11.8±2.0; n=6) than in vehicle-treated cells (6.4±0.7; n=6). Furthermore, in the ruptured patch-clamp configuration, although we observed a significant increase in ICa,L in vehicle-treated cells in response to isoproterenol, in cells treated with colchicine, we saw no significant increase (P>0.05) in ICa,L after exposure to isoproterenol (Figure 4DDown). By contrast to the study of Gomez et al15 performed in the ruptured patch configuration, using perforated patch there was no difference (P>0.05) in current-voltage relationships under basal conditions between vehicle-treated cells and colchicine-treated cells (Figure 5Down). There was a tendency for the ICa,L response to isoproterenol to be enhanced in cells treated with colchicine; however, this difference was not significant (2-way repeated-measures ANOVA).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4. Comparison of the effect of colchicine on ICa,L recorded using the perforated and ruptured configuration of the patch-clamp technique in rat ventricular myocytes. A and B, Individual traces of ICa,L recorded in amphotericin-perforated (A) and ruptured (B) patch-clamped myocytes. Membrane potential was stepped to 0 mV from a holding potential of -80 mV after a 300-ms prepulse to -40 mV to inactivate INa. ICa,L was recorded in cells after exposure to vehicle (Veh) or 10 µmol/L colchicine (Col) for 2 to 4 hours under basal conditions ({circ}) and at steady state after perfusion with 1 µmol/L isoproterenol (•). C and D, Mean data in perforated (C) and ruptured (D) patch-clamped myocytes. Open bars are under basal conditions, and hatched bars are in the presence of 1 µmol/L isoproterenol. All data are mean+SEM of 6 to 8 observations. *P<0.05, **P<0.01 compared with respective group under basal conditions; +P<0.05 compared with respective vehicle-treated group (Student’s t test). A significant increase in ICa,L in response to isoproterenol was present in all cells except colchicine-treated cells studied using the ruptured patch-clamp technique.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 5. Effect of colchicine on ICa,L-voltage relationship recorded in rat ventricular myocytes. Current-voltage relationships were measured using amphotericin-perforated patch-clamped myocytes exposed to either vehicle (A) or 10 µmol/L colchicine (B) for 2 to 4 hours. ICa,L was measured under basal conditions ({circ}) and at steady state after perfusion with 1 µmol/L isoproterenol (•). In both panels, ICa,L amplitude is normalized to the peak current recorded under basal conditions. Points are mean±SEM of 4 to 10 observations. Before normalization of data, there was no difference in the magnitude of ICa,L under basal conditions between vehicle- and colchicine-treated cells (2-way repeated-measures ANOVA).

Figure 6Down summarizes the effects of colchicine on the response of contraction, [Ca2+]i transient, ICa,L measured in perforated patch, and ICa,L measured in ruptured patch configuration to isoproterenol. This figure shows clearly that in cells with an intact sarcolemma (measurements of contraction, [Ca2+]i transient, and ICaL under perforated patch-clamp conditions), colchicine had no effect on the ratio of isoproterenol-stimulated to basal values of the parameters. In fact there is a (nonsignificant) tendency for this ratio to be increased in colchicine-treated cells (P>0.05). However, in ruptured patch-clamped cells, the ratio of isoproterenol-stimulated to basal value is significantly reduced (P<0.05) in colchicine-treated cells compared with vehicle-treated cells.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 6. Effect of colchicine on response to isoproterenol of contraction, [Ca2+]i transient, and ICa,L measured using perforated (PP) and ruptured (RP) patch-clamp in rat ventricular myocytes. A, Cell shortening (measured as a percentage of resting cell length). B, Amplitude of [Ca2+]i transient (expressed as fura-2 ratio units). C, ICa,L measured using amphotericin-perforated patch-clamp (in pA/pF). D, ICa,L measured using the ruptured configuration of the patch-clamp technique (in pA/pF). ICa,L was measured during a step depolarization from -80 to 0 mV as in Figure 4Up. Bars indicate the ratio of isoproterenol-stimulated:basal values in cells exposed to either 10 µmol/L colchicine for 2 to 4 hours (hatched bars) or vehicle (open bars). Values are mean±SEM for 6 to 12 observations. The only significant effect of colchicine was recorded in the ruptured whole-cell configuration. *P<0.05 compared with ratio recorded in vehicle-treated cells.

Effect of Colchicine on Cell Size in Ruptured Patch Configuration
The ruptured patch configuration may cause dialysis of the cell with the contents of the microelectrode; this can lead to dilution of intracellular contents and alterations in cell shape. To test whether an interaction between the effects of colchicine and a change in cell shape might account for the results obtained in ruptured patch, cell size was recorded immediately and at 8 to 15 minutes after rupture of the membrane patch (at 10.4±1.2 and 13.3±1.1 minutes in vehicle- and colchicine-treated cells, respectively; P>0.05). In vehicle-treated cells, neither resting cell length (105±8 versus 104±7 µm; n=5) nor cell width (18.1±2.9 versus 17.5±2.6 µm) changed during the course of the experiment (P>0.05). In colchicine-treated cells, although there was no significant change (P>0.05) in resting cell length (99.0±3.1 versus 97.8±3.0 µm; n=6), cell width was significantly smaller (P<0.001) at the later time point (25.2±1.5 versus 22.8±1.4 µm).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
When the dynamic network of microtubules within the cardiac cell is proliferated either pathologically (in some models of pressure-overload hypertrophy) or chemically (by taxol), contractility is reduced.3 4 5 6 7 However, in the absence of prior hypertrophic proliferation, evidence strongly suggests that microtubule disruption by colchicine does not modulate contraction.3 4 5 6 8 9 10 11 12 13 14 However, Gomez et al15 recently presented data in Circulation Research showing that in ruptured patch-clamped myocytes, microtubule disruption by colchicine can increase ICa,L and the [Ca2+]i transient, effects that would be expected to increase contraction, unless myofilament sensitivity was concurrently depressed (for review, see Calaghan and White18 ). We have addressed the apparent inconsistency highlighted by the findings of Gomez et al15 by undertaking a comprehensive investigation of the effect of colchicine on contraction, [Ca2+]i, and ICa,L.

The ability of colchicine to disrupt microtubules under the conditions of our experiments was confirmed by the use of immunofluorescence confocal microscopy. We saw a 43% reduction in immunofluorescence intensity in cells treated with 10 µmol/L colchicine for 2 hours; this degree of reduction in immunofluorescence intensity is comparable with the 38% reduction observed in the study of Gomez et al15 after a 2-hour incubation of rat ventricular myocytes with 1 µmol/L colchicine.

Our findings that microtubule disruption had no effect on the amplitude of the [Ca2+]i transient or contraction in intact cells nor on the amplitude of ICa,L under perforated patch-clamp conditions are consistent with those of many contractile studies reported in the literature.3 4 5 6 8 9 10 11 12 13 14 In addition, we saw no effect of colchicine on the change in amplitude of contraction, [Ca2+]i transient (see Palmer et al19 ), or ICa,L in response to the ß-adrenoceptor agonist isoproterenol. We conclude that in cells with an intact sarcolemma and cytosol, microtubule disruption by colchicine does not activate adenylyl cyclase. These results contrast with measurements of [Ca2+]i transients and ICa,L obtained by Gomez et al15 in ruptured patch-clamped cells.

However, our own observations on ICa,L under ruptured patch conditions agree with those of Gomez et al.15 In cells treated with colchicine, basal ICa,L is enhanced and the response to isoproterenol is blunted. Therefore, it appears that these data and those of Gomez et al15 are related to some aspect of the ruptured patch-clamp configuration. Our use of K+-based pipette solution for the ruptured patch experiments allows us to exclude the possibility that Cs+-based solutions15 contributed to these effects.20

Gomez et al15 proposed that, on microtubule disruption, adenylyl cyclase is activated via nucleotide exchange to Gs protein by accumulation of free tubulin within the cell. Our lack of response to colchicine in intact cells and under perforated patch conditions argues against this explanation. In ruptured patch conditions, inhibitors of adenylyl cyclase blunt the response to colchicine15 suggesting that the combination of microtubule disruption and the ruptured patch configuration work together to activate adenylyl cyclase. This configuration can cause more dialysis of the intracellular milieu with the contents of the recording microelectrode than is seen in the perforated patch configuration.21 22 Indeed run-down of ICa,L in ruptured patch-clamped cells is a common observation that has been related to intracellular dialysis.23 One possible mechanism that could account for the effect of colchicine in ruptured patch-clamped cells is the loss, through dialysis, of cellular tubulin (or a tubulin-Gi complex) resulting in decreased cellular activity of Gi. In support of this hypothesis, there is evidence that tubulin can activate Gi24 25 and, in the cardiac cell, Gi is in excess of Gs.26 In our experiments, colchicine appeared to oppose the effect of the ruptured configuration on ICa,L run-down.

The ruptured patch-clamp configuration may also be associated with changes in cell shape, and an alternative explanation to account for the effect of colchicine on ruptured patch-clamped myocytes is based on our observation that disruption of the microtubular network by colchicine was associated with a reduction in cell width under ruptured patch conditions. Shrinkage of rat cardiac myocytes has been shown to activate adenylyl cyclase.27 Alterations in cell size might reflect changes in stress on the sarcolemma and t-tubular system, and there is evidence that adenylyl cyclase is mechanosensitive.28 29 Early time-dependent potentiation of ICa,L after establishment of the whole-cell configuration in ruptured patch has been ascribed to mechanical effects of this configuration.30

There are several reports in the literature of pathological conditions (including ischemia, hypothyroidism, and chronic pressure-overload hypertrophy)19 31 32 in which the cardiac microtubule network is diminished and in which cellular levels of tubulin may be decreased. Based on our observations and re-interpretation of the findings of Gomez et al,15 the possibility that the loss of cellular tubulin activates adenylyl cyclase or that microtubule disruption renders adenylyl cyclase more susceptible to mechanical stimulation has important implications for such conditions.


*    Acknowledgments
 
This work was sponsored by the British Heart Foundation and a Wellcome Trust Biomedical Collaborative Grant.


*    Footnotes
 
Original received October 12, 2000; revision received February 7, 2001; accepted February 7, 2001.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Ganote C, Armstrong S. Ischemia and the myocyte cytoskeleton: review and speculation. Cardiovasc Res. 1994;27:1387–1403.

2. Hein S, Kostin S, Heling A, Maeno Y, Scaper J. The role of the cytoskeleton in heart failure. Cardiovasc Res. 2000;45:273–278.[Abstract/Free Full Text]

3. Tsutsui H, Ishihara K, Cooper G. Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science. 1993;260:682–687.[Abstract/Free Full Text]

4. Tsutsui H, Tagawa H, Kent RL, McCollam PL, Ishihara K, Nagatsu M, Cooper G. Role of microtubules in contractile dysfunction of hypertrophied cardiocytes. Circulation. 1994;90:533–555.[Abstract/Free Full Text]

5. Ishibashi Y, Tsutsui H, Yamamoto S, Takahashi M, Imanakayoshida K, Yoshida T, Urabe Y, Sugimachi M, Takeshita A. Role of microtubules in myocyte contractile dysfunction during cardiac hypertrophy in the rat. Am J Physiol. 1996;40:H1978–H1987.

6. Tagawa H, Rozich JD, Tsutsui H, Narishige T, Kuppuswamy D, Sato H, McDermott PJ, Koide M, Cooper G. Basis for increased microtubules in pressure-hypertrophied cardiocytes. Circulation. 1996;93:1230–1243.[Abstract/Free Full Text]

7. Howarth FC, Calaghan SC, Boyett MR, White E. Effect of the microtubule polymerizing agent taxol on contraction, Ca2+ transient and L-type Ca2+ current in rat ventricular myocytes. J Physiol. 1999;516:409–419.[Abstract/Free Full Text]

8. Cicogna AC, Brooks WW, Hayes JA, Robinson KG, Sen S, Conrad CH, Bing OHL. Effect of chronic colchicine administration on the myocardium of the aging spontaneously hypertensive rat. Mol Cell Biochem. 1997;166:45–54.[Medline] [Order article via Infotrieve]

9. Cicogna AC, Robinson KG, Conrad CH, Singh K, Squire R, Okoshi MP, Bing OHL. Direct effects of colchicine on myocardial function: studies in hypertrophied and failing spontaneously hypertensive rats. Hypertension. 1999;33:60–65.[Abstract/Free Full Text]

10. Hongo K, Brette F, Haroon MM, White E. Mechanisms associated with the negative inotropic effect of deuterium oxide in single rat ventricular myocytes. Exp Physiol. 2000;85:133–142.[Abstract]

11. Bailey BA, Dipla K, Li S, Houser SR. Cellular basis of contractile derangements of hypertrophied feline ventricular myocytes. J Mol Cell Cardiol. 1997;29:1823–1835.[Medline] [Order article via Infotrieve]

12. Zile MR, Koide M, Sato H, Ishiguro TY, Conrad CH, Buckley JM, Morgan JP, Cooper G IV. Role of microtubules in the contractile dysfunction of hypertrophied myocardium. J Am Coll Cardiol. 1999;33:250–260.[Abstract/Free Full Text]

13. Collins JF, Pawloski-Dahm C, Davis MG, Ball N, Dorn GW II, Walsh RA. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol. 1996;28:1435–1443.[Medline] [Order article via Infotrieve]

14. Tagawa H, Koide M, Sato H, Zile MR, Carabello BA, Cooper G IV. Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading. Circ Res. 1998;82:751–761.[Abstract/Free Full Text]

15. Gomez AM, Kerfant BG, Vassort G. Microtubule disruption modulates Ca2+ signaling in rat cardiac myocytes. Circ Res. 2000;86:30–36.[Abstract/Free Full Text]

16. Frampton JE, Orchard CH, Boyett MR. Diastolic, systolic and sarcoplasmic reticulum [Ca2+] during inotropic interventions in isolated rat myocytes. J Physiol. 1991;437:351–375.[Abstract/Free Full Text]

17. Calaghan SC, White E, Colyer J. Coordinated changes in cAMP, phosphorylated phospholamban, Ca2+ and contraction following ß-adrenergic stimulation of rat heart. Pflugers Arch. 1998;436:948–956.[Medline] [Order article via Infotrieve]

18. Calaghan SC, White E. The role of calcium in the response of cardiac muscle to stretch. Prog Biophys Mol Biol. 1999;71:59–90.[Medline] [Order article via Infotrieve]

19. Palmer BM, Valent S, Holder EL, Weinberger HD, Bies RD. Microtubules modulate cardiomyocyte ß-adrenergic response in cardiac hypertrophy. Am J Physiol. 1998;275:H1707–H1716.[Abstract/Free Full Text]

20. Kawai M, Hussain M, Orchard CH. Cs+ inhibits spontaneous Ca2+ release from the sarcoplasmic reticulum of skinned cardiac myocytes. Am J Physiol. 1998;275:H422–H430.[Abstract/Free Full Text]

21. Rae J, Cooper K, Gates P, Watsky M. Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods. 1991;37:15–26.[Medline] [Order article via Infotrieve]

22. Pusch M, Neher E. Rates of diffusional exchange between small cells and a measuring patch pipette. Pflugers Arch. 1988;411:204–211.[Medline] [Order article via Infotrieve]

23. Pelzer D, Pelzer S, McDonald TF. Properties and regulation of calcium channels in muscle cells. Rev Physiol Biochem Pharmacol. 1990;114:104–207.

24. Rasenick MM, Wang N. Exchange of guanine nucleotides between tubulin and GTP-binding proteins that regulate adenylate cyclase: cytoskeletal modification of neuronal signal transduction. J Neurochem. 1988;51:300–311.[Medline] [Order article via Infotrieve]

25. Hatta S, Ozawa H, Saito T, Ohshika H. Participation of tubulin in the stimulatory regulation of adenylyl cyclase in rat cerebral cortex membranes. J Neurochem. 1995;64:1343–1350.[Medline] [Order article via Infotrieve]

26. Sugden PH, Bogoyevitch MA. Intracellular signalling through protein kinases in the heart. Cardiovasc Res. 1995;30:478–492.[Medline] [Order article via Infotrieve]

27. Smogorzewski M, Galfayan V, Massry SG. High glucose concentration causes a rise in [Ca2+]i of cardiac myocytes. Kidney Int. 1998;53:1237–1243.[Medline] [Order article via Infotrieve]

28. Calaghan SC, Colyer J, White E. Cyclic AMP but not phosphorylation of phospholamban increases during the slow response to stretch in ferret papillary muscle. Pflugers Arch. 1998;437:780–782.

29. Watson PA, Giger KE, Kempinski AM. Type I and type VIII adenylyl cyclases constitute a family whose activation is coupled to cellular deformation through the action of calcium-calmodulin. Biochem Cell Biol. 1995;73:367–372.[Medline] [Order article via Infotrieve]

30. Tiaho F, Nargeot J, Richard S. Repriming of L-type calcium currents revealed during early whole-cell patch-clamp recordings in rat ventricular cells. J Physiol. 1993;463:367–389.[Abstract/Free Full Text]

31. Hein S, Scheffold T, Schaper J. Ischaemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium. J Thorac Cardiovasc Surg. 1995;110:89–98.[Abstract/Free Full Text]

32. Samuel J-L, Marotte F, Delcayre C, Rappaport L. Microtubule reorganization is related to rate of heart hypertrophy in rat. Am J Physiol. 1986;251:H1118–H1125.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ishibashi, M. Takahashi, Y. Isomatsu, F. Qiao, Y. Iijima, H. Shiraishi, J. M. Simsic, C. F. Baicu, J. Robbins, M. R. Zile, et al.
Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1270 - H1285.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. S. Harris, C. F. Baicu, C. H. Conrad, M. Koide, J. M. Buckley, M. Barnes, G. Cooper IV, and M. R. Zile
Constitutive properties of hypertrophied myocardium: cellular contribution to changes in myocardial stiffness
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2173 - H2182.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calaghan, S. C.
Right arrow Articles by White, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calaghan, S. C.
Right arrow Articles by White, E.
Related Collections
Right arrow Contractile function
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Ion channels/membrane transport